AI & Imaging
Elucid launches Plaque-IQ lesion inspection tool
The new tool allows physicians to analyze plaque composition and burden at the lesion level in coronary and carotid vessels.
Section
All News
Every story we've published, newest first. 296 articles.
Business
Telix and Regeneron target solid tumors in $2.1B radiopharma pact
The companies will co-develop and co-commercialize next-generation radiopharmaceutical therapies, with Telix receiving $40M upfront and eligibility for up to $2.1B in milestones.
AI & Imaging
QT Imaging-Olea viewer brings multimodality breast imaging into one interface
The QT Imaging-Olea Viewer brings breast acoustic CT, mammography, digital breast tomosynthesis, MRI, and ultrasound into 1 interface.
Business
Nanox.ARC rollout expands through Arkansas distributor
Digital X-Ray Imaging will market, install, and support the FDA-cleared multisource digital tomosynthesis system across Arkansas.
Practice
Radiologists see $571K average pay and 9% growth in 2025
Radiology ranked 3rd in average total compensation at $571K and posted 9% compensation growth in 2025, according to Medscape.
Practice
MITA PET Group rebrands as RMTA
The Radiopharmaceutical Manufacturers and Theranostics Alliance will expand beyond diagnostic radiopharmaceuticals to include theranostics.
Conferences
Microbot begins U.S. launch of Liberty endovascular robot
The full market release began at the Society of Interventional Radiology annual meeting after a limited rollout across selected U.S. sites.
Practice
Radical adds 6F catheter to FDA-cleared neurovascular access lineup
The 6F neurovascular access catheter is the company’s 3rd FDA-cleared catheter and is designed to broaden options for middle meningeal artery embolization and radial access procedures.
Business
Regeneron taps Telix platform for solid-tumor radiopharma programs
The companies will co-develop radiopharmaceutical therapies and radiodiagnostics across multiple solid tumor targets.
Practice
ACR fund backs screening for patients outside cancer guidelines
The Cancer Doesn’t Care Fund will support pilot programs, community partnerships, technology development, and policy research for earlier cancer detection.